BACKGROUND Gastric cancer(GC)is the fifth most common and the fourth most lethal malignant tumour in the world.Most patients are already in the advanced stage when they are diagnosed,which also leads to poor overall s...BACKGROUND Gastric cancer(GC)is the fifth most common and the fourth most lethal malignant tumour in the world.Most patients are already in the advanced stage when they are diagnosed,which also leads to poor overall survival.The effect of posto-perative adjuvant chemotherapy for advanced GC is unsatisfactory with a high rate of distant metastasis and local recurrence.AIM To investigate the safety and efficacy of a programmed cell death 1(PD-1)inhibitor combined with oxaliplatin and S-1(SOX)in the treatment of Borrmann large type III and IV GCs.METHODS A retrospective analysis(IRB-2022-371)was performed on 89 patients with Borrmann large type III and IV GCs who received neoadjuvant therapy(NAT)from January 2020 to December 2021.According to the different neoadjuvant treatment regimens,the patients were divided into the SOX group(61 patients)and the PD-1+SOX(P-SOX)group(28 patients).RESULTS The pathological response(tumor regression grade 0/1)in the P-SOX group was significantly higher than that in the SOX group(42.86%vs 18.03%,P=0.013).The incidence of ypN0 in the P-SOX group was higher than that in the SOX group(39.29%vs 19.67%,P=0.05).The use of PD-1 inhibitors was an independent factor affecting tumor regression grade.Meanwhile,the use of PD-1 did not increase postoperative complications or the adverse effects of NAT.CONCLUSION A PD-1 inhibitor combined with SOX could significantly improve the rate of tumour regression during NAT for patients with Borrmann large type III and IV GCs.展开更多
The World Health Organization (WHO) standard assay for determining antibody level is the rapid fluorescent focus inhibition test (RFFIT) and is used to determine the degree of immunity after vaccination against rabies...The World Health Organization (WHO) standard assay for determining antibody level is the rapid fluorescent focus inhibition test (RFFIT) and is used to determine the degree of immunity after vaccination against rabies. To compare the difference in RFFIT results between the laboratories of The National Institute of Infectious Disease in Japan (NIID) and the Chinese Centre for Disease Control (CCDC) as well the influence of the choice of standard serum (STD) for the detection, the two laboratories detection methods were simultaneously manipulated by RFFIT. The reference serums used in NIID and the WHO standard serum used in CCDC were compared in the same RFFIT detection to determine the titer of four sera samples C1, S1, S2 and S4 in parallel, and the titers of the detected sera samples were calculated using the standard formula for neutralizing antibody titer. No significant difference was found in RFFIT methods from the two laboratories and the RFFIT testing procedures of the two laboratories have good consistency. However, different titers were obtained with the tentative internal standard serum (TI-STD) produced by adjusting to 2.0 IU of WHO standard serum in NIID and the WHO STD. The titer determined with the TI-STD was higher than that determined with WHO STD, This difference appears to be significant and requires further investigation.展开更多
To provide a foundation for the development of rapid and specific methods for the diagnosis of rabies virus infection, anti-rabies virus monoclonal antibodies were prepared and rabies virus nucleoprotein and human rab...To provide a foundation for the development of rapid and specific methods for the diagnosis of rabies virus infection, anti-rabies virus monoclonal antibodies were prepared and rabies virus nucleoprotein and human rabies virus vaccine strain (PV strain) were used as immunogens to immunize 6-8 week old female BALB/c mice. Spleen cells and SP2/0 myeloma cells were fused according to conventional methods: the monoclonal cell strains obtained were selected using the indirect immunofluorescence test; this was followed by preparation of monoclonal antibody ascitic fluid; and finally, systematic identification of subclass, specificity and sensitivity was carried out. Two high potency and specific monoclonal antibodies against rabies virus were obtained and named 3B12 and 4A12, with ascitic fluid titers of 1:8000 and 1:10000, respectively. Both belonged to the IgG2a subclass. These strains secrete potent, stable and specific anti-rabies virus monoclonal antibodies, which makes them well suited for the development of rabies diagnosis reagents.展开更多
Background:China still suffers heavily from rabies,although reported human cases continue to decrease year over year.There are far fewer laboratory-confirmed human cases than clinically diagnosed cases,which is a big ...Background:China still suffers heavily from rabies,although reported human cases continue to decrease year over year.There are far fewer laboratory-confirmed human cases than clinically diagnosed cases,which is a big problem that needs to be addressed.In this report,we summarize analyses of all specimens from human cases tested in our laboratory over the past 15 years,in order to promote laboratory diagnosis of rabies.Methods:From 2005 to 2019,a total of 271 samples from 164 suspected rabies cases were collected from local hospitals by the local Centers for Disease Control and Prevention(CDCs)in China.Saliva,cerebrospinal fluid(CSF),serum(blood)and urine were collected for ante-mortem diagnosis,and brain tissue,neck skin tissue and cornea were collected for post-mortem diagnosis.All of the specimens were tested by reverse transcription-polymerase chain reaction(RT-PCR),and brain tissues were also tested using fluorescent antibody test(FAT).The number of positive test results obtained using different fluids or tissues,and at different stages of the disease,were compared using a chi-square test and a more effective sampling program is recommended.Results:As the national reference laboratory for rabies surveillance in China,our laboratory has tested 271 samples from 164 suspected rabies cases collected by local CDCs since 2005.We found that saliva gave the highest number of positive test results(32%),compared with CSF and other fluids.We also found that serum or blood specimens collected in the last 3 days of life can test positive by RT-PCR.Conclusions:Serum or blood samples collected in the last 3 days of a patient’s life can be used to measure viral RNA,which means that serum samples,as well as saliva and CSF,can be used to detect viral RNA for anti-mortem diagnosis of rabies.Because of our findings,we have modified our“National Surveillance Project for Human Rabies”,by adding the collection and testing of serum samples from the end of the survival period.This will improve our national surveillance and laboratory diagnosis of human rabies.展开更多
Background:The injection of rabies immune globulin(RIG)is of the utmost importance in the management of category III exposures to rabies-suspect animals.Because of the high cost and limited availability of existing RI...Background:The injection of rabies immune globulin(RIG)is of the utmost importance in the management of category III exposures to rabies-suspect animals.Because of the high cost and limited availability of existing RIG,one possible replacement for RIG is monoclonal antibodies(MAbs)against the rabies virus(RABV).Consequently,it is necessary to determine the neutralizing activity of the MAbs against rabies viruses,especially street rabies virus.However,the method to detect the neutralizing activity of MAbs against street rabies virus remains undefined.Methods:To establish a method for detecting the neutralizing activity of MAbs against street rabies virus,we constructed a library consisting of 12 strains of street RABV from 11 provinces in China.Using this street RABV library and the Reed-Muench formula,we established a method for detecting the neutralizing titer of the MAbs.The reliability and repeatability of the method were evaluated by repeatedly measuring the neutralizing activity of a MAb and a post vaccination serum.Results:A total of 12 strains of street RABV were chosen for inclusion in the street RABV library,which covered six Chinese lineages(China I-China VI)and grew to high titers in N2A cells(>105 FFD50/ml).On the basis of the library,we constructed the method to detect the neutralizing activity of the MAbs.The results of repeatedly measuring the MAbs and positive serum showed excellent reliability and repeatability of the method established in this study.Conclusions:This study established a street RABV library reflecting the epidemiological features of Chinese rabies viruses,which provides a platform for detecting the neutralizing activity of MAbs against rabies viruses circulating in China.展开更多
基金Supported by Medical Science and Technology Project of Zhejiang Province(2022KY085).
文摘BACKGROUND Gastric cancer(GC)is the fifth most common and the fourth most lethal malignant tumour in the world.Most patients are already in the advanced stage when they are diagnosed,which also leads to poor overall survival.The effect of posto-perative adjuvant chemotherapy for advanced GC is unsatisfactory with a high rate of distant metastasis and local recurrence.AIM To investigate the safety and efficacy of a programmed cell death 1(PD-1)inhibitor combined with oxaliplatin and S-1(SOX)in the treatment of Borrmann large type III and IV GCs.METHODS A retrospective analysis(IRB-2022-371)was performed on 89 patients with Borrmann large type III and IV GCs who received neoadjuvant therapy(NAT)from January 2020 to December 2021.According to the different neoadjuvant treatment regimens,the patients were divided into the SOX group(61 patients)and the PD-1+SOX(P-SOX)group(28 patients).RESULTS The pathological response(tumor regression grade 0/1)in the P-SOX group was significantly higher than that in the SOX group(42.86%vs 18.03%,P=0.013).The incidence of ypN0 in the P-SOX group was higher than that in the SOX group(39.29%vs 19.67%,P=0.05).The use of PD-1 inhibitors was an independent factor affecting tumor regression grade.Meanwhile,the use of PD-1 did not increase postoperative complications or the adverse effects of NAT.CONCLUSION A PD-1 inhibitor combined with SOX could significantly improve the rate of tumour regression during NAT for patients with Borrmann large type III and IV GCs.
基金Grant from National Institute of Infectious Diseases(NIID)National Department Public Benefit Research Foundation (201103032)
文摘The World Health Organization (WHO) standard assay for determining antibody level is the rapid fluorescent focus inhibition test (RFFIT) and is used to determine the degree of immunity after vaccination against rabies. To compare the difference in RFFIT results between the laboratories of The National Institute of Infectious Disease in Japan (NIID) and the Chinese Centre for Disease Control (CCDC) as well the influence of the choice of standard serum (STD) for the detection, the two laboratories detection methods were simultaneously manipulated by RFFIT. The reference serums used in NIID and the WHO standard serum used in CCDC were compared in the same RFFIT detection to determine the titer of four sera samples C1, S1, S2 and S4 in parallel, and the titers of the detected sera samples were calculated using the standard formula for neutralizing antibody titer. No significant difference was found in RFFIT methods from the two laboratories and the RFFIT testing procedures of the two laboratories have good consistency. However, different titers were obtained with the tentative internal standard serum (TI-STD) produced by adjusting to 2.0 IU of WHO standard serum in NIID and the WHO STD. The titer determined with the TI-STD was higher than that determined with WHO STD, This difference appears to be significant and requires further investigation.
基金National Department Public Benefit Research Foundation (201103032)Pathogens Network Monitoring Technology Research (2008ZX10004-008)
文摘To provide a foundation for the development of rapid and specific methods for the diagnosis of rabies virus infection, anti-rabies virus monoclonal antibodies were prepared and rabies virus nucleoprotein and human rabies virus vaccine strain (PV strain) were used as immunogens to immunize 6-8 week old female BALB/c mice. Spleen cells and SP2/0 myeloma cells were fused according to conventional methods: the monoclonal cell strains obtained were selected using the indirect immunofluorescence test; this was followed by preparation of monoclonal antibody ascitic fluid; and finally, systematic identification of subclass, specificity and sensitivity was carried out. Two high potency and specific monoclonal antibodies against rabies virus were obtained and named 3B12 and 4A12, with ascitic fluid titers of 1:8000 and 1:10000, respectively. Both belonged to the IgG2a subclass. These strains secrete potent, stable and specific anti-rabies virus monoclonal antibodies, which makes them well suited for the development of rabies diagnosis reagents.
基金supported by the Natural Science Foundation of Jiangsu Province(BK20202002)the National Natural Science Foundation of China(81603409,31900808,81902480,21977021,31570832,31971146,and 31971042)+4 种基金Innovation and Entrepreneurship Talent Program of Jiangsu ProvinceState Key Laboratory of Utilization of Woody Oil Resource(2019XK2002)the Natural Science Foundation of Hunan Province(2018JJ1012)Hunan“Huxiang”High-level Talent Program(2021)“Xing Yao”Leading Scholars of China Pharmaceutical University(2021)。
基金This work was supported by the National Science and Technology Major Project(2017ZX10104001,2018ZX10201002,2018ZX10713002,2018ZX10734404,2018ZX10102001)the National Program on Key Research Project of China(2016YFD0500400)+1 种基金the National Key R&D Program of China(2017YFC1200503)the Science and Technology Project of Chinese Center for Disease Control and Prevention(JY18–2-12).
文摘Background:China still suffers heavily from rabies,although reported human cases continue to decrease year over year.There are far fewer laboratory-confirmed human cases than clinically diagnosed cases,which is a big problem that needs to be addressed.In this report,we summarize analyses of all specimens from human cases tested in our laboratory over the past 15 years,in order to promote laboratory diagnosis of rabies.Methods:From 2005 to 2019,a total of 271 samples from 164 suspected rabies cases were collected from local hospitals by the local Centers for Disease Control and Prevention(CDCs)in China.Saliva,cerebrospinal fluid(CSF),serum(blood)and urine were collected for ante-mortem diagnosis,and brain tissue,neck skin tissue and cornea were collected for post-mortem diagnosis.All of the specimens were tested by reverse transcription-polymerase chain reaction(RT-PCR),and brain tissues were also tested using fluorescent antibody test(FAT).The number of positive test results obtained using different fluids or tissues,and at different stages of the disease,were compared using a chi-square test and a more effective sampling program is recommended.Results:As the national reference laboratory for rabies surveillance in China,our laboratory has tested 271 samples from 164 suspected rabies cases collected by local CDCs since 2005.We found that saliva gave the highest number of positive test results(32%),compared with CSF and other fluids.We also found that serum or blood specimens collected in the last 3 days of life can test positive by RT-PCR.Conclusions:Serum or blood samples collected in the last 3 days of a patient’s life can be used to measure viral RNA,which means that serum samples,as well as saliva and CSF,can be used to detect viral RNA for anti-mortem diagnosis of rabies.Because of our findings,we have modified our“National Surveillance Project for Human Rabies”,by adding the collection and testing of serum samples from the end of the survival period.This will improve our national surveillance and laboratory diagnosis of human rabies.
基金This work was supported by the National Program on Key Research Project of China(No.2016YFD0500400)the National Natural Science Foundation of China(No.31500152)the China Mega-Project for Infectious Disease(No.2017ZX10104001–004-001).
文摘Background:The injection of rabies immune globulin(RIG)is of the utmost importance in the management of category III exposures to rabies-suspect animals.Because of the high cost and limited availability of existing RIG,one possible replacement for RIG is monoclonal antibodies(MAbs)against the rabies virus(RABV).Consequently,it is necessary to determine the neutralizing activity of the MAbs against rabies viruses,especially street rabies virus.However,the method to detect the neutralizing activity of MAbs against street rabies virus remains undefined.Methods:To establish a method for detecting the neutralizing activity of MAbs against street rabies virus,we constructed a library consisting of 12 strains of street RABV from 11 provinces in China.Using this street RABV library and the Reed-Muench formula,we established a method for detecting the neutralizing titer of the MAbs.The reliability and repeatability of the method were evaluated by repeatedly measuring the neutralizing activity of a MAb and a post vaccination serum.Results:A total of 12 strains of street RABV were chosen for inclusion in the street RABV library,which covered six Chinese lineages(China I-China VI)and grew to high titers in N2A cells(>105 FFD50/ml).On the basis of the library,we constructed the method to detect the neutralizing activity of the MAbs.The results of repeatedly measuring the MAbs and positive serum showed excellent reliability and repeatability of the method established in this study.Conclusions:This study established a street RABV library reflecting the epidemiological features of Chinese rabies viruses,which provides a platform for detecting the neutralizing activity of MAbs against rabies viruses circulating in China.